Zealand Pharma taps Generate’s AI in obesity deal worth up to $1.2 billion
Zealand's AI-driven obesity drug collaboration could redefine treatment strategies, emphasizing multispecific proteins for complex conditions. The post Zealand Pharma taps Generate’s AI in obesity deal worth up to $1.2 billion appeared first on Crypto Briefing.
AI summary
Zealand Pharma has partnered with Generate Biomedicines to use AI in developing obesity drugs, in a deal valued at up to $1.2 billion. The collaboration focuses on multispecific proteins for complex metabolic conditions. This is a biotech industry development with no direct connection to cryptocurrency markets, so it is unlikely to affect crypto prices or investor sentiment.
Impact
5
%
Conviction
0
%
